PRIME MEMBER EXCLUSIVE | 3 Months Free Trial
Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
Unreported Results and Legal Risks
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
A recent FDA reminder revealed that nearly 30% of certain clinical trials still lack publicly reported results—raising concerns about transparency and bias in scientific research. In this episode, we explore how missing or selectively reported data can distort the scientific record and influence litigation outcomes. We break down the role of Daubert and Rule 702, and discuss how attorneys can identify gaps in the evidence to challenge expert reliability. This is a must-listen for anyone navigating the intersection of science, regulation, and the law.
Read the full article
What the Scientific Record Leaves Out: Unreported Evidence and Expert Reliability Under Daubert
About the author
Gloria Malpass, Ph.D.